The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
BEIJING - The head of multinational pharmaceutical giant AstraZeneca’s China arm is under investigation in the country, the firm said. Mr Leon Wang, president of AstraZeneca China, is ...
AstraZeneca, a global biopharmaceutical company that develops and commercializes prescription medicines, became a household ...
Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...
Zacks.com on MSN4d
Astrazeneca (AZN) Rises But Trails Market: What Investors Should KnowAstrazeneca (AZN) closed at $71.42 in the latest trading session, marking a +0.38% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.41%. On the other hand, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback